Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
research chain—from basic science to drug and biomarker development. Infla-Med emphasizes translational impact by integrating clinical expertise and promoting collaboration between researchers and clinicians
-
, such as FWO Access to state-of-the-art facilities and training in advanced techniques. Opportunities for career development, networking, and mentorship. Support for presenting at international conferences
-
manufacturing sector is a plus. You show interest in sustainable development and the transition to a more sustainable society. You show interest in cleantech and environmental technology. Experience with funding
-
, cutting-edge microscopy, immunology, technology development, and bioinformatics. VIB provides a highly interactive environment and ample training opportunities for its researchers. The VIB-UAntwerp Center
-
plasma-/bio-/chemo-catalysts under the supervision of Professor Joke Hadermann. The PhD project is part of a broader research effort focused on developing innovative technologies for the sustainable
-
in plants, using tip-growing root hair cells as a model. This exceptionally dynamic and elegant pathway is still poorly understood, yet it is crucial for plant development and its interaction with
-
, development, function and evolution. Our research combines behavioural, evolutionary and ecological approaches involving longitudinal and experimental field studies as well as controlled experiments performed
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
set a course for the future – a future that you can help to shape. The EMAT research group at the Faculty of Science (University of Antwerp) is seeking to fill a PhD position on the development
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models